Ladona M G, Park S S, Gelboin H V, Hammar L, Rane A
Division of Clinical Pharmacology, University Hospital, Uppsala, Sweden.
Biochem Pharmacol. 1988 Dec 15;37(24):4735-41. doi: 10.1016/0006-2952(88)90345-0.
Monoclonal antibodies (MAbs) raised to rat liver cytochrome P-450s induced by phenobarbital, 3-methylcholanthrene, and pregnenolone-16 alpha-carbonitrile were used to detect these epitope specific P-450s in human abortion fetuses 14-24 weeks of age. This was performed using a Western blot technique. In parallel, ECOD was determined in the same tissue specimens. Of seven different MAbs used MAb PCN 2-13-1/C2 was the only one that immunodetected a cytochrome P-450 band with Western blot analyses of human fetal liver microsomes. This band was consistently detected in all fetal liver specimens studied although the intensity varied among samples. No bands were detected in microsomal preparations from adrenal and renal tissues obtained from the same fetuses. The human adult liver microsomal specimens also contained a MAb PCN 2-13-1/C2 identified cytochrome P-450 band. ECOD activity was detected in all but one of the human fetal livers and varied between 0.22 and 47.5 pmol min-1 mg protein-1, as compared to 113 to 489 pmol min-1 mg protein-1 in human adult livers. In all of the fetuses except one the adrenal ECOD activity (0.63-37.0 pmol min-1 mg protein-1) exceeded that in the liver. The renal ECOD activities were, however, low. The hepatic and adrenal ECOD activities correlated with each other (r = 0.95). Although the ECOD activity is a function of several different P-450s there was also a correlation (r = 0.78) between the ECOD activity and the MAb immunodetected protein band intensity in Western blots of human fetal liver microsomes. The presence of a MAb PCN 2-13-1/C2 identified band in fetal liver microsomes may be indicative of a steroid-dependent effect in fetal life.
用针对苯巴比妥、3-甲基胆蒽和孕烯醇酮-16α-腈诱导的大鼠肝脏细胞色素P-450产生的单克隆抗体(MAb),来检测14至24周龄的人类流产胎儿中这些具有表位特异性的P-450。这是通过蛋白质印迹技术进行的。同时,在相同的组织标本中测定了乙氧异吩唑酮-O-脱乙基酶(ECOD)。在所使用的七种不同单克隆抗体中,单克隆抗体PCN 2-13-1/C2是唯一一种在对人类胎儿肝脏微粒体进行蛋白质印迹分析时免疫检测到细胞色素P-450条带的抗体。尽管不同样本之间强度有所差异,但在所有研究的胎儿肝脏标本中均一致检测到了这条带。在从同一胎儿获取的肾上腺和肾脏组织的微粒体制剂中未检测到条带。人类成人肝脏微粒体标本中也含有一条单克隆抗体PCN 2-13-1/C2识别的细胞色素P-450条带。除一个胎儿肝脏外,在所有人类胎儿肝脏中均检测到了ECOD活性,其活性在0.22至47.5 pmol·min⁻¹·mg蛋白⁻¹之间,相比之下,人类成人肝脏中的活性为113至489 pmol·min⁻¹·mg蛋白⁻¹。在除一个胎儿外的所有胎儿中,肾上腺的ECOD活性(0.63至37.0 pmol·min⁻¹·mg蛋白⁻¹)超过了肝脏中的活性。然而,肾脏的ECOD活性较低。肝脏和肾上腺的ECOD活性相互相关(r = 0.95)。尽管ECOD活性是几种不同P-450的功能,但在人类胎儿肝脏微粒体的蛋白质印迹中,ECOD活性与单克隆抗体免疫检测到的蛋白条带强度之间也存在相关性(r = 0.78)。胎儿肝脏微粒体中存在单克隆抗体PCN 2-13-1/C2识别的条带可能表明胎儿期存在类固醇依赖性效应。